CompletedNCT00841269
Uridine for depression in adolescents with bipolarity
About this title
Oral Uridine for Treatment of Bipolar Depression in Adolescents
Read the official source — NCT00841269Medication studyAges 13–18United States
Understand this study
Who was this study for?
Listed age limits: 13 years to 18 years.
- Listed locations
- Salt Lake CitySee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateMay 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 42
- Sponsor
- University of Utah
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 13 Years to 18 Years
- Official registry ID
- NCT00841269
- Official title
Show the full official title
Oral Administration of Uridine for Treatment of Bipolar Depression in Adolescents: A Magnetic Resonance Spectroscopy Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Salt Lake City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Utah, a university.
Did this study involve medication?
Yes. The study involved medication, including Uridine.
Who was this study for?
Listed age limits: 13 years to 18 years.
